Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer

Journal of Clinical Oncology

Volumn 26, Issue 20, 2008, Pages 3338-3345

  Julian, Thomas B ^a   Blumencranz, Peter ^b   Deck, Kenneth ^b   Whitworth, Pat ^b   Berry, Donald A ^b   Berry, Scott M ^b   Rosenberg, Anne ^b   Chagpar, Anees B ^b   Reintgen, Douglas ^b   Beitsch, Peter ^b   Simmons, Rache ^b   Saha, Sukamal ^b   Mamounas, Eleftherios P ^b   Giuliano, Armando ^b  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19; MAMMAGLOBIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEMALE; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; INTRAOPERATIVE PERIOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; ADENOCARCINOMA; BAYES THEOREM; BREAST TUMOR; CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; FOLLOW UP; GENETICS; IMMUNOHISTOCHEMISTRY; MASTECTOMY; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PEROPERATIVE CARE; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY; SURVIVAL; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BAYES THEOREM; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; FOLLOW-UP STUDIES; FROZEN SECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE CARE; LYMPHATIC METASTASIS; MALE; MASTECTOMY; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 49149118042     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.14.0665     Document Type: Article

References (22)

1. Turner RR, Hansen NM, Stern SL, et al: Intra-operative examination of the sentinel lymph node for breast carcinoma staging. Am J Clin Pathol 112:627-634, 1999
2. Giuliano AE, Dale PS, Turner RR, et al: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222:394-401, 1995
3. Morton DL: Intra-operative lymphatic mapping and sentinel lymphadenectomy: Community standard care or clinical investigation? Cancer J Sci Am 3:328-330, 1997
4. Smeets A, Christiaens MR: Implications of the sentinel lymph node procedure for local and systemic adjuvant treatment. Curr Opin Oncol 17:539-544, 2005
5. Schulze T, Mucke J, Markwardt J, et al: Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. J Surg Oncol 93:109-119, 2006
6. Cserni G, Amendoeira I, Apostolikas N, et al: Pathological work-up of sentinel lymph nodes in breast cancer: Review of current data to be considered for the formulation of guidelines. Eur J Cancer 39:1654-1667, 2003
7. Rubio IT, Korourian S, Cowan C, et al: Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer. Ann Surg Oncol 5:689-694, 1998
8. Schrenk P, Rieger R, Shamiyeh A, et al: Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88:608-614, 2000
9. Blumencranz P, Deck KB, Whitworth PW, et al: Clinical evaluation of a molecular assay for the detection of metastasis in breast sentinel lymph nodes. Arch Pathol Lab Med 130:1397, 2006 (suppl)
10. Blumencranz P, Deck K, Whitworth PW, et al: Multiple molecular assay has improved sensitivity over histological intra-operative nodal metastases tests for breast cancer patients: Results from a large multi-center trial. Breast Cancer Res Treat 100:S1-299, 2006 (suppl 1)
11. Lespagnard L, Ma Y, Nogaret J, et al: Clinical validation of a molecular assay for the detection of metastases in breast sentinel lymph nodes. Arch Pathol Lab Med 130:1398, 2006 (suppl)
12. Palazzo J, Minimo C, Schroer K, et al: Rapid molecular assay for detection of nodal metastases had higher sensitivity compared to frozen section intraoperative histology in subjects with different types of invasive breast carcinomas. J Mol Diagn 8:661, 2006 (suppl)
13. Pieretti M, Moench K, Paturzo ST, et al: Reproducibility of a real time RT-PCR assay for the rapid detection of nodal metastases in breast cancer patients. J Mol Diagn 8:664, 2006 (suppl)
14. Cao W, Backus J, Vargo J, et al: Additional markers support results in a molecular breast sentinel lymph node diagnostic assay. Breast Cancer Res Treat 100:S1-299, 2006 (suppl 1)
15. Zehentner BK, Dillon DC, Jiang Y, et al: Application of a multigene reverse transcription-PCR assay for detection of mammaglobin and complementary transcribed genes in breast cancer lymph nodes. Clin Chem 48:1225-1231, 2002
16. Backus J, Laughlin T, Wang Y, et al: Identification and characterization of optimal gene expression markers for detection of breast cancer metastasis. J Mol Diagn 7:327-336, 2005
17. White RL, Wilke LG: Update on the NSABP and ACOSOG breast cancer sentinel node trials. Am Surg 70:420-424, 2004
18. Roberts CA, Beitsch PD, Litz CE, et al: Interpretive disparity among pathologists in breast sentinel lymph node evalution. Am J Surg 186:324-329, 2003
19. Groen RS, Oosterhuis AWJ, Boers JE: Pathologic examination of sentinel lymph nodes in breast cancer by a single haematoxylin-eosin slide versus serial sectioning and immunocytokeratin staining: Clinical implications. Breast Cancer Res Treat 105:1-5, 2007
20. Pargaonkar AS: Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer. Arch Pathol Lab Med 127:701-705, 2003
21. Motomura K, Komoike Y, Inaji H, et al: Muliple sectioning and immunohistochemical staining of sentinel nodes in patients with breast cancer. Br J Surg 89:1032-1034, 2002
22. Bleiweiss IJ, Nagi CS, Jaffer S: Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma. J Clin Oncol 24:2013-2018, 2006